Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software (SEDDI)
Recruitment status was: Recruiting
A drug interaction (DI) is the mutual action of two drugs in a way that they can increase their action, even to a toxic level, or reduce it to its minimum.
People elder than 65 years old have theirs biological ability to metabolized and eliminate drugs impaired. Even more, they tend to suffer from many diseases, are treated for many physicians, and receive many drugs for those conditions. If hospitalized older people are prone to receive a greater number of drugs. This scenario is the worst to suffer from adverse drug events and DI, which in turn compromise more the health and even life of hospitalized older people.
Many computerized strategies have been developed to prevent those problems. In this trial the investigators use on line software to early detect DI that could endanger health or life of hospitalized older patients.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Transversal, Multicentric Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software in Córdoba, Argentina|
- Early detect DI in hospitalized elder patients [ Time Frame: One year and 6 months ] [ Designated as safety issue: No ]
|Study Start Date:||June 2009|
|Estimated Study Completion Date:||December 2010|
|Estimated Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Patients elder than 65 years old hospitalized for any reason.
Other: on line software to detect DI early on
Patients hospital records will be reviewed on the day of admission to assess all their indication using on line software to early detect drug interactions.
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT00850330
|Hospital Nacional de Clínicas|
|Cordoba, Argentina, x5009|
|Clínica Privada Colombo|
|Córdoba, Argentina, x5000|
|Principal Investigator:||Gabriel S Iraci, MD, Prof||Catedra de Farmacología, Hospital Nacional de Clínicas, Universidad Nacional de Córdoba|